Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

GSK presents new pan-Akt inhibitor at AACR meeting

April 17, 2007

Poniard begins phase I trial of oral picoplatin

April 17, 2007

MEK inhibitor ARRY-704 begins phase I trial in cancer patients

April 17, 2007

New phase II trial studies EndoTAG-1 for triple receptor negative breast cancer

April 17, 2007

Recent patents impart new therapeutic agents for cancer

April 17, 2007

Satraplatin NDA accepted for priority review

April 16, 2007

MB-07133 safe and active in an ongoing clinical study in patients with liver cancer

April 16, 2007

Next-generation taxane crosses the blood-brain barrier and is active against brain tumors

April 16, 2007

Novel transcription inhibitor reduces VEGF levels in patients

April 16, 2007

Food effects on the pharmacokinetics of PD-325901 in humans

April 16, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...